CN112522386A - 一种检测mecp2基因拷贝数变异的试剂盒 - Google Patents
一种检测mecp2基因拷贝数变异的试剂盒 Download PDFInfo
- Publication number
- CN112522386A CN112522386A CN202011453523.3A CN202011453523A CN112522386A CN 112522386 A CN112522386 A CN 112522386A CN 202011453523 A CN202011453523 A CN 202011453523A CN 112522386 A CN112522386 A CN 112522386A
- Authority
- CN
- China
- Prior art keywords
- mecp2
- copy number
- gene
- kit
- primer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 101150083522 MECP2 gene Proteins 0.000 title claims abstract description 14
- 238000000034 method Methods 0.000 claims abstract description 12
- 230000003321 amplification Effects 0.000 claims description 37
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 37
- 238000001514 detection method Methods 0.000 abstract description 9
- 238000002474 experimental method Methods 0.000 abstract description 7
- 238000012795 verification Methods 0.000 abstract description 3
- 108090000623 proteins and genes Proteins 0.000 description 27
- 108020004414 DNA Proteins 0.000 description 20
- 238000004090 dissolution Methods 0.000 description 17
- 239000000523 sample Substances 0.000 description 15
- 238000005457 optimization Methods 0.000 description 13
- 239000003153 chemical reaction reagent Substances 0.000 description 6
- 238000012163 sequencing technique Methods 0.000 description 6
- 238000012360 testing method Methods 0.000 description 5
- 238000011529 RT qPCR Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000007850 fluorescent dye Substances 0.000 description 4
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 3
- 102100039124 Methyl-CpG-binding protein 2 Human genes 0.000 description 3
- 238000004364 calculation method Methods 0.000 description 3
- 239000000969 carrier Substances 0.000 description 3
- 238000012217 deletion Methods 0.000 description 3
- 230000037430 deletion Effects 0.000 description 3
- 230000008506 pathogenesis Effects 0.000 description 3
- 208000026350 Inborn Genetic disease Diseases 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000000137 annealing Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 208000016361 genetic disease Diseases 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 206010058314 Dysplasia Diseases 0.000 description 1
- 208000014094 Dystonic disease Diseases 0.000 description 1
- 108700024394 Exon Proteins 0.000 description 1
- 206010071602 Genetic polymorphism Diseases 0.000 description 1
- 208000036626 Mental retardation Diseases 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 208000029726 Neurodevelopmental disease Diseases 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 239000012470 diluted sample Substances 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 239000012154 double-distilled water Substances 0.000 description 1
- 208000010118 dystonia Diseases 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 208000021302 gastroesophageal reflux disease Diseases 0.000 description 1
- 230000007614 genetic variation Effects 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000001046 green dye Substances 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000011880 melting curve analysis Methods 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 238000005065 mining Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000003950 pathogenic mechanism Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 239000013074 reference sample Substances 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6858—Allele-specific amplification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/166—Oligonucleotides used as internal standards, controls or normalisation probes
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
SampleP | SampleF | SampleM | STD | |
MECP2-L | 31.08 | 24.17 | 24.8 | 23.35 |
MECP2-M | 30.69 | 24.42 | 24.58 | 23.92 |
MECP2-R | 30.65 | 24.79 | 24.42 | 23.12 |
RP | 23.79 | 23.52 | 23.16 | 23.35 |
SampleP | SampleF | SampleM | |
MECP2-L | 零拷贝 | 单拷贝 | 单拷贝 |
MECP2-M | 零拷贝 | 单拷贝 | 单拷贝 |
MECP2-R | 零拷贝 | 单拷贝 | 单拷贝 |
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011453523.3A CN112522386A (zh) | 2020-12-11 | 2020-12-11 | 一种检测mecp2基因拷贝数变异的试剂盒 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011453523.3A CN112522386A (zh) | 2020-12-11 | 2020-12-11 | 一种检测mecp2基因拷贝数变异的试剂盒 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN112522386A true CN112522386A (zh) | 2021-03-19 |
Family
ID=74998841
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011453523.3A Pending CN112522386A (zh) | 2020-12-11 | 2020-12-11 | 一种检测mecp2基因拷贝数变异的试剂盒 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112522386A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114231610A (zh) * | 2021-11-25 | 2022-03-25 | 长沙金域医学检验实验室有限公司 | 一种检测scn1a基因拷贝数变异的试剂盒 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103014142A (zh) * | 2011-09-26 | 2013-04-03 | 复旦大学 | 用于诊、查染色体微缺失综合征的分子组合探针 |
CN103614472A (zh) * | 2013-11-27 | 2014-03-05 | 扬州创日畜牧科技有限公司 | 一种检测猪基因组拷贝数变异的pcr试剂盒及检测方法 |
CN103740827A (zh) * | 2014-01-13 | 2014-04-23 | 香港中文大学深圳研究院 | 胎儿dna芯片及其应用 |
CN104046699A (zh) * | 2014-07-08 | 2014-09-17 | 上海交通大学医学院附属瑞金医院 | F9基因拷贝数变异检测试剂盒 |
CN110305948A (zh) * | 2018-03-20 | 2019-10-08 | 中国科学院上海生命科学研究院 | 一种检测自闭症相关基因ube3a拷贝数的试剂和方法 |
CN111172248A (zh) * | 2020-02-26 | 2020-05-19 | 上海晶准生物医药有限公司 | 一种基于片段分析技术验证拷贝数变异的通用试剂盒 |
-
2020
- 2020-12-11 CN CN202011453523.3A patent/CN112522386A/zh active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103014142A (zh) * | 2011-09-26 | 2013-04-03 | 复旦大学 | 用于诊、查染色体微缺失综合征的分子组合探针 |
CN103614472A (zh) * | 2013-11-27 | 2014-03-05 | 扬州创日畜牧科技有限公司 | 一种检测猪基因组拷贝数变异的pcr试剂盒及检测方法 |
CN103740827A (zh) * | 2014-01-13 | 2014-04-23 | 香港中文大学深圳研究院 | 胎儿dna芯片及其应用 |
CN104046699A (zh) * | 2014-07-08 | 2014-09-17 | 上海交通大学医学院附属瑞金医院 | F9基因拷贝数变异检测试剂盒 |
CN110305948A (zh) * | 2018-03-20 | 2019-10-08 | 中国科学院上海生命科学研究院 | 一种检测自闭症相关基因ube3a拷贝数的试剂和方法 |
CN111172248A (zh) * | 2020-02-26 | 2020-05-19 | 上海晶准生物医药有限公司 | 一种基于片段分析技术验证拷贝数变异的通用试剂盒 |
Non-Patent Citations (1)
Title |
---|
唐丹霞等: "3 例 MECP2 重复综合征临床分析和文献复习", 《中国当代儿科杂志》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114231610A (zh) * | 2021-11-25 | 2022-03-25 | 长沙金域医学检验实验室有限公司 | 一种检测scn1a基因拷贝数变异的试剂盒 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2786696C (en) | Oligonucleotides and methods for detecting pik3ca mutations | |
KR20100063050A (ko) | 디지털 pcr에 의한 다양한 길이의 핵산의 분석 | |
CN101838683B (zh) | 一种kras基因和/或braf基因的核苷酸突变位点的检测方法 | |
AU2014203213A1 (en) | Diagnostic markers for ankylosing spondylitis and uses thereof | |
CN107012234B (zh) | 检测y染色体微缺失的多重pcr引物组、试剂盒和应用 | |
CN112522386A (zh) | 一种检测mecp2基因拷贝数变异的试剂盒 | |
US20120148574A1 (en) | Diagnostic Markers for Ankylosing Spondylitis | |
CN117305437A (zh) | 一种人运动神经元存活基因的检测引物探针组合、试剂盒及检测方法 | |
CN116479103B (zh) | 一种检测脊髓性肌萎缩症相关基因的试剂盒 | |
CN112481371A (zh) | 一种检测plp1基因拷贝数变异的试剂盒 | |
CN112522385A (zh) | 一种检测dnm2基因拷贝数变异的试剂盒 | |
CN112322726A (zh) | 一种检测otc基因拷贝数变异的试剂盒 | |
CN116004775A (zh) | 一种人运动神经元拷贝数定量的引物探针组合物、试剂盒及方法 | |
CN111172248B (zh) | 一种基于片段分析技术验证拷贝数变异的通用试剂盒 | |
TWI674320B (zh) | 用以預斷吉特曼症候群的方法及套組 | |
KR101728023B1 (ko) | Pcr―ldr을 이용한 atp7b 유전자의 돌연변이 검출 | |
CN117737222B (zh) | 用于Rh血型系统抗原基因分型的方法及组合物和试剂盒 | |
CN114231610A (zh) | 一种检测scn1a基因拷贝数变异的试剂盒 | |
CN118109584A (zh) | 用于多囊卵巢综合征风险预测的snp标志物及其应用 | |
EP1601792B1 (en) | Method for the identification of colorectal tumors | |
CN117025733A (zh) | 一种探针与引物组合物、检测体系及其在aldh2基因单核苷酸多态性检测中的应用 | |
CN117757921A (zh) | 一种基因检测试剂盒及基因检测方法 | |
CN117512085A (zh) | 一种用于检测hla-dpb1基因分型的引物组及试剂盒 | |
CN116103417A (zh) | 用于幽门螺杆菌vacA基因分型的实时荧光PCR特异性引物和探针组合 | |
CN117343995A (zh) | 一种用于定量检测rna融合的组合物及检测方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20211223 Address after: 530007 fourth floor, building 1, phase II, Fengda Road headquarters base, high tech Zone, Nanning, Guangxi Zhuang Autonomous Region Applicant after: GUANGXI KINGMED MEDICAL LABORATORY CO.,LTD. Address before: Room 101-801, floor 1-8, building D1 and D2, jinruilugu science and Technology Park, No.28 Lutian Road, high tech Development Zone, Changsha City, Hunan Province Applicant before: Changsha Jinyu medical laboratory Co.,Ltd. |
|
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210319 |